{{Rsnum
|rsid=2304204
|Gene=IRF3
|Chromosome=19
|position=49665763
|Orientation=minus
|GMAF=0.3779
|Gene_s=BCL2L12,IRF3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.3 | 37.2 | 3.5
| HCB | 57.1 | 34.6 | 8.3
| JPT | 61.1 | 32.7 | 6.2
| YRI | 8.8 | 33.3 | 57.8
| ASW | 8.8 | 40.4 | 50.9
| CHB | 57.1 | 34.6 | 8.3
| CHD | 59.6 | 34.9 | 5.5
| GIH | 54.5 | 39.6 | 5.9
| LWK | 4.6 | 35.2 | 60.2
| MEX | 36.8 | 54.4 | 8.8
| MKK | 6.4 | 42.3 | 51.3
| TSI | 40.2 | 45.1 | 14.7
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19213861
|Title=No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus
}}

{{PMID Auto
|PMID=21859832
|Title=Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
|OA=1
}}

{{PMID|19434718|OA=1
}} Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

{{PMID|22294846|OA=1
}} No association between IRF3 polymorphism and susceptibility to hepatitis B virus infection in Chinese patients.

{{PMID Auto
|PMID=25130328
|Title=Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from Systemic Lupus Erythematosus patients: Novel genetic associations in Mexican-mestizo population
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}